Fatigue typically resolves as the body adjusts to appetite changes and reduced caloric intake
Its effective at transporting fatty acids into mitochondria for energy production, supporting fat burning during workouts
Semaglutide not only improves glycemic control, evidenced by significant reductions in HbA1c (e.g., 0.54-0.6% in T1D and 1.2-1.8% in T2D) and fasting glucose, but also positively influences body composition by reducing fat mass, particularly visceral fat, while largely preserving lean muscle mass
While semaglutide works differently from traditional cholesterol-lowering medications, it offers additional benefits, especially for patients with type 2 diabetes and obesity
Potential synergy with peptides related to the regulation of the GH/IGF-1 axis is discussed
Samsung Biologics announced Sunday it would pay CHF 1.46 billion ($1.81 billion) in an all-cash tender offer to acquire PolyPeptide Group AG, a Swiss contract drug manufacturer that builds the molecular ingredients at the heart of the GLP-1 obesity and diabetes drugs that tens of millions of patients rely on meaning Samsung is not just buying a company but a foothold in one of the most constrained supply chains in modern medicine
